- Home
- MREO vs NLOP Comparison
MREO vs NLOP Comparison
Compare MREO & NLOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- NLOP
- Stock Information
- Founded
- MREO 2015
- NLOP N/A
- Country
- MREO United Kingdom
- NLOP United States
- Employees
- MREO N/A
- NLOP N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- NLOP
- Sector
- MREO Health Care
- NLOP
- Exchange
- MREO Nasdaq
- NLOP Nasdaq
- Market Cap
- MREO 424.5M
- NLOP 445.8M
- IPO Year
- MREO N/A
- NLOP N/A
- Fundamental
- Price
- MREO $2.65
- NLOP $31.31
- Analyst Decision
- MREO Strong Buy
- NLOP Strong Buy
- Analyst Count
- MREO 7
- NLOP 1
- Target Price
- MREO $7.71
- NLOP $46.00
- AVG Volume (30 Days)
- MREO 977.7K
- NLOP 72.9K
- Earning Date
- MREO 05-13-2025
- NLOP 01-01-0001
- Dividend Yield
- MREO N/A
- NLOP N/A
- EPS Growth
- MREO N/A
- NLOP N/A
- EPS
- MREO N/A
- NLOP N/A
- Revenue
- MREO N/A
- NLOP $127,453,000.00
- Revenue This Year
- MREO N/A
- NLOP N/A
- Revenue Next Year
- MREO $54.07
- NLOP N/A
- P/E Ratio
- MREO N/A
- NLOP N/A
- Revenue Growth
- MREO N/A
- NLOP N/A
- 52 Week Low
- MREO $1.58
- NLOP $22.36
- 52 Week High
- MREO $5.02
- NLOP $34.38
- Technical
- Relative Strength Index (RSI)
- MREO 63.52
- NLOP 61.59
- Support Level
- MREO $2.11
- NLOP $30.69
- Resistance Level
- MREO $2.27
- NLOP $31.56
- Average True Range (ATR)
- MREO 0.14
- NLOP 0.53
- MACD
- MREO 0.03
- NLOP 0.05
- Stochastic Oscillator
- MREO 94.74
- NLOP 86.55
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About NLOP Net Lease Office Properties of Beneficial Interest
Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns a diversified portfolio of office properties that are primarily leased to corporate tenants on a single-tenant, net-lease basis. Its net leases generally specify a base rent with rent increases and require the tenant to pay substantially all costs associated with operating and maintaining the property. Its portfolio includes approximately 1.2 million square feet of Green-Certified Buildings, 2 LEED-certified buildings, and 1 BREEAM-certified building.